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1.16.3.1) is a multifunctional copper-containing oxi-
dase. This protein was discovered in 1944 in vertebrate
plasma [1]. In humans it accounts for 95% of plasma
copper. The physiological meaning of ferroxidase
activity of CP was elucidated. Ceruloplasmin is impli-



















ions and is involved in four-electron transfer to oxygen
giving rise to water, thus hindering nonenzymatic oxi-
dation of iron producing free radicals. The inherited
defect of the CP gene (aceruloplasminemia) is a sys-
temic disorder of iron metabolism and degeneration of
the central nervous system, the pancreas, and other tis-
sues [3]. In addition, CP exhibits superoxide dismutase
activity [4] and glutathione-dependent peroxidase
activity [5] and serves as the physiological inhibitor of
the prooxidant leukocyte enzyme myeloperoxidase [6].
The first CP crystals were grown as early as 1960





Å resolution. Ceruloplasmin is a monomer
composed of six domains with six tightly bound copper
ions [8]. Domains 2, 4, and 6 contain homologous
mononuclear copper-binding sites. The trinuclear site is
located between domains 1 and 6. In addition, there are
two labile metal-binding sites, half of which in native




















 ions in the labile sites of CP
suggested that these sites play an important role in iron
oxidation [9]. The binding sites of the inhibitor (azide
ion) and various substrates (biogenic and synthetic
amines) were revealed [10]. Recently, the structure of




Å resolution [11]. This made it












There are several factors that make it difficult to
grow CP crystals of high diffraction quality. Cerulo-
plasmin is a large multidomain molecule with a weight
of 132 kDa and a carbohydrate content of 7–8%. This
protein is very sensitive to proteolytic degradation. The
isolation of undegraded and stable CP has remained a
difficult problem since its discovery [12–15]. Cerulo-
plasmin samples contain impurities of prothrombin
[16] and unidentified metalloproteinases [17], owing to
which it is necessary to use proteinase inhibitors in all
steps of CP isolation [18]. In the course of isolation, CP
is prone to aggregation, which also hinders the crystal-
lization.
We isolated CP by the method described earlier
[19]. This method allows the preparation of homoge-
neous storage-stable undegraded CP. According to this
method, proteinase inhibitors (EDTA and phenylmeth-
ylsulfonyl fluoride) were added to blood plasma. Impu-
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—The three-dimensional structure of ceruloplasmin (CP) with unoccupied labile metal-binding sites











lution, respectively. Crystallization was performed with the use of storage-stable CP, which was prepared in the







the orthorhombic space group, which had been earlier unknown for CP. Ceruloplasmin with the unoccupied
labile sites crystallized in the trigonal crystal form. The differences in intermolecular contacts observed in the






 binding are described. It was suggested that the labile sites are multifunctional and can both bind metal


























adsorbed with the use of arginine- and heparin-
Sepharose. Since the presence of metalloproteinase in
CP samples was reported earlier [17], we estimated the








In the present study, we describe the characteristic





Å resolution, the trigonal crystal form) and











resolution, the orthorhombic crystal form). The differ-
ences in the intermolecular contacts observed in the
trigonal and orthorhombic crystal structures of CP are




 ions to CP is dis-






 binding in the labile sites were revealed. Hypothe-
ses concerning the role of the labile metal-binding sites
of CP are suggested.
MATERIALS AND METHODS
 
Isolation of CP and analysis of samples.
 
 Cerulo-
plasmin was isolated from blood plasma by affinity
chromatography on protamine-Sepharose [19]. Blood
plasma of healthy people (3 l) was diluted twofold with
100 mM sodium acetate buffer, pH 5.5, with the addi-
tion of EDTA and phenylmethylsulfonyl fluoride to the
final concentrations of 1 and 0.1 mM, respectively. This









 cm) equilibrated with 50 mM sodium acetate







0.005 in the flow-through solution; and eluted with a





NaCl in 50 mM sodium acetate buffer, pH 5.5). Blue
fractions were combined and cooled on ice. An equal







was added to these fractions. After 20 min, the mixture











natant was withdrawn, and an equal volume of an etha-








) was added. After
20 min, the mixture was centrifuged under the same
conditions. The blue CP-containing precipitate was dis-
solved in PBS (0.15 M NaCl, 10 mM sodium phosphate










 to remove undissolved impurities. Then CP was fil-









 cm). Ceruloplasmin was eluted with
PBS in the free volume of the column. Then CP was



















 < 0.003 in the flow-through solution and eluted




-HCl buffer, pH 7.4, at
the maximum rate. The CP-containing fractions were
combined, diluted threefold with water, and filtered









 cm). Ceruloplasmin was eluted with PBS in the
free volume.
Another CP sample was isolated according to the













M. The CP samples were concentrated with the use
of a Vivaspin 20 cell to the final concentration of
80 mg/ml. The homogeneity of CP was verified by PAG
electrophoresis in the absence of detergents [20]. Ceru-





nisidine [21], which allowed us to reveal possible oligo-
meric forms. The degree of proteolytic degradation of
CP was estimated by Ds-Na-PAG electrophoresis [22].
The concentration of homogeneous CP was determined













 = 0.0741 ml/mg per












 ratio related to the ratio
of type-I copper ions to aromatic amino-acid residues
in CP was used as the criterion of the quality of purified
CP. The atomic absorption analysis was carried out on
an AAS-5000 PerkinElmer instrument.
 
Crystallization and X-ray data collection.
 
 Crys-
tals of CP complexes were grown by the vapor-diffu-




. The crystallization solution analo-
gous to that used earlier [21] contained 3–7% PEG








 mM NaCl, and 50 mM sodium acetate
buffer, pH 5.5. Blue crystals with a size of 0.08–0.2 mm
appeared within 5–7 days; 30% glycerol or 28% PEG
400 were used as the cryoprotector. The binding of cal-
cium and nickel in the crystals was confirmed by X-ray
fluorescence. X-ray diffraction data were collected on
the beamline BW6 at DESY (Hamburg) at 100 K using
a MAR CCD detector. Anomalous-scattering data were







-binding sites. The optimal data-col-
lection parameters were chosen with the use of the
BEST program [23]. The data were processed using the
DENZO and SCALEPACK programs [24]. The X-ray
data-collection statistics are given in Table 1.
 
Structure solution and refinement.
 
 The structures
were solved by the molecular replacement method with
the use of the MOLREP program [26] starting from the
atomic coordinates of CP, whose structure had been




Å resolution [8]. The refinement
was carried out with the use of the REFMAC program










 factors for CP containing no copper ions in the
labile sites were 21.4 and 26.5%, respectively. For the

















was 18.6% (25.1%). The Ramachandran plot shows








 torsion angles in the
amino-acid residues are in the most-favored regions,
12.8 and 12.2% are in the additionally allowed regions,
0.5 and 0.6% are in the generously allowed regions, and
0.1 and 0.1% are in the disallowed regions for CP con-
taining no copper ions in the labile sites and the CP
complex, respectively. Characteristics of the models are
given in Table 2.
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 Human CP isolated in the













0.052, which is larger than that determined for CP in
the earlier studies on crystallization (0.048) [8]. The
analysis of CP by Ds-Na-PAG electrophoresis showed








132 kDa (Fig. 1a). The PAG electrophoresis
in the absence of detergents revealed no oligomeric
forms of CP (Figs. 1b and 1c). The electrophoretic







 are analogous to those of the former sam-






 ions to the starting blood
plasma did not lead to an increase in the degree of deg-
radation of CP in the course of isolation, which could
result from the activation of metalloproteinase. The







The atomic absorption analysis showed that both CP
samples contain 5.95 ± 0.05 mol of copper per mole of
the protein. No proteolytic degradation of CP was
observed by Ds-Na-PAG electrophoresis after storage
of CP in the presence of the bacteriostatic agent
(sodium merthiolate) for two months at 37°ë.
General structural organization of CP. Cerulo-
plasmin is a pseudohexamer consisting of six domains
related by a noncrystallographic threefold axis. The
structural organization of each domain is typical of
cupredoxins. The domains contain a β barrel with a
long loop between the first and last β sheets, which cov-
ers the top of the barrel (Fig. 2). The presence of these
long flexible loops, which do not form strong bonds
with the compact core, on the molecular surface is,
apparently, responsible for high sensitivity of CP to
proteolytic degradation. The limited proteolysis with
trypsin affords the same fragments; i.e., the cleavage
always proceeds at the particular peptide bonds located
after R481, R701, and K887 [13, 15]. The replacement
of these amino-acid residues by site-directed mutagen-
esis produced human CP resistant to proteolysis [28].
The residues R481, R701, and K887 are conserved pro-
teolysis sites, because the loops covering the tops of the
β barrels in CP from other animals contain residues
homologous to those mentioned above. In addition,
some other peptide bonds in these loops are also sus-
ceptible to proteolytic attack, for example, by
elastase [29].
The structure of human CP was solved at the pres-
ently highest resolution (2.6 Å). The reliability and
accuracy of the structural information obtained by
X-ray diffraction depend primarily on the spatial reso-
lution of the diffraction experiment. In the case of CP,
an improvement of the resolution allowed us to reveal
the positions of particular amino-acid residues, which
had not been included in the earlier model. The orienta-
tion of the residue His980, which serves as a ligand for
the copper ion in the trinuclear center and plays an
important role in the catalytic properties, was deter-
mined with higher accuracy (see Fig. 3). The same ori-
entation of this residue was observed in the CP struc-
ture solved at 2.8 Å resolution [11]. In the earlier
model, the residue His980 is twisted by about ~87° [8].
       
Table 1.  X-ray data-collection statistics
CP-Ca2+ CP-Ca2+ + Ni2+ CP-Ca2+ + Ni2+
Wavelength, Å* 0.97 0.97 1.48
Resolution range, Å 30–2.6 30–2.95 30–3.25
Last resolution shell, Å 2.64–2.6 3.0–2.95 3.31–3.25
Sp. gr. P3221 I222 I222








Number of independent reflections 64294 (3104)* 34841 (1729) 60352 (3018)
Completeness, % 95.9 (93.4) 82.3 (83.2) 99.7 (100)
I/σ(I) 17.7 (1.75) 10.6 (2.64) 8.9 (3.6)
Rmerge 4.5 (30.5) 5.7 (23.5) 8.7 (35.6)
* The values for the last resolution shell are given in parentheses.
       
Table 2.  Characteristics of the refined structures of the ceru-
loplasmin complexes
CP-Ca2+ CP-Ca2+ + Ni2+




R/Rfree factor, % 21.4/26.5 18.6/25.1
rms deviations from ideal
values:
for interatomic distances 0.020 0.020
for bond angles, deg 1.45 1.48
Temperature factor, Å2 47.8 48.4
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In spite of the higher resolution compared to that for
the structures solved earlier [8, 11] and the use of unde-
graded CP, we failed to determine the positions of the
amino-acid residues involved in the interdomain loops
339–346, 475–482, 885–891, and 1041–1046. At the
same time, the region 700–709 containing the proteol-
ysis site R701 was reliably determined in all known CP
structures. The factors responsible for this situation are
considered below.
We found three Na+ ions and one Ca2+ ion bound to
CP. This is analogous to the structure solved earlier at
2.8 Å resolution [11]. The sodium-binding sites are
located between domains 1 and 3, domains 3 and 4, and
domains 5 and 6. The ë‡2+ ion is located in domain 1
and is coordinated by D127 and D128 as bidentate
ligands, the main-chain oxygen atoms of the residues
K109 and Q124, and two water molecules. The average
distance to the ligands is 2.42 Å.
In spite of the fact that, according to biochemical
data, three to four Ca2+ ions can be bound to the CP
molecule [30], no other binding sites were found for
this metal in CP. It is known that the presence of Ca2+
ions in solution influences the binding of CP to AE-aga-
rose [30]. It is commonly accepted that the selective
affinity of CP for chelate sorbents (in particular, for AE-
agarose) is attributed to the presence of clusters of neg-
atively charged amino acids on the surface of the CP
molecule [31]. Actually, we found the following evolu-
tionally conserved clusters arranged as a broad area on
the surface of human CP: 242–255, 586–595, 605–616,
740–752, 924–933, and 940–955 [19]. In our experi-
ments the synthetic polyanionic peptides corresponding
to the D–Q–V–D–K–E–D–E–D–F–Q–E (586–597), E–
V–E–W–D–Y–S–P–Q–R–E–W–E (740–752), and D–
E–N–E–S–W–Y–L–D–D (924–933) regions elute CP
from AE-agarose [32], which confirms the importance
of these regions for the binding to chelate sorbents. The
influence of Ca2+ ions on the binding of CP to AE-aga-
rose is, apparently, associated with the ion-exchange
effect rather than with specific binding, as was sug-
gested earlier [30]. The only specific Ca2+-binding site
was located in domain 1 of the molecule remote from
the above-mentioned negatively charged clusters.
Crystal packing of CP. Ceruloplasmin crystallized
in two different space groups. The trigonal crystal
structure was obtained earlier [8, 11]. In the present
study, we obtained a previously unknown orthorhombic
modification. This crystal modification was obtained
for the CP complex with nickel under the same crystal-
lization conditions as those used for the preparation of
the trigonal modification.
Both crystal modifications of CP are characterized
by high water content (70.0 and 67.3% for the trigonal




Fig. 1. Electrophoretic analysis of human ceruloplasmin
(20 µg per lane). (a) Ds-Na-PAG electrophoresis, Coo-
massie R-250 staining, the arrows on the left indicating the
molecular-weight markers (in kDa); (b, c) PAG electro-
phoresis in the absence of detergents: (b) Coomassie R-250
staining, (c) o-dianisidine staining.
(a) (b)
Fig. 2. Secondary structure of ceruloplasmin projected (a) along the threefold axis and (b) perpendicular to the threefold axis.
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the factors responsible for a rather low resolution at
which the X-ray diffraction data were collected for the
crystals of CP. Conceivably, the presence of long flexi-
ble loops on the molecular surface hinders the forma-
tion of a more close-packed crystal structure as well. As
a consequence of the presence of these loops, there are
rather wide channels in the crystal structure.
The trigonal structure contains channels with a vir-
tually triangular cross section (Fig. 4a) running along
the threefold axes, which are located in the centers of
the channels. The size of the cross section is approxi-
mately ~110 × 110 × 110 Å. The contacts between the
molecules are formed by amino-acid residues from four
regions (Table 3). The largest region, 697–716,
includes the residue R701, which is linked to the resi-
dues P829 and E834 of the adjacent molecule by hydro-
gen bonds (Fig. 5). The method used for the protein iso-
lation in the earlier studies did not ensure complete
inhibition of impurity proteinases, and CP was not,
apparently, subjected to proteolysis at R701 in the crys-
tals owing to the involvement of the loop 697–716 con-
taining the latter residue in intermolecular contacts
formed upon protein crystallization.
The orthorhombic and trigonal structures have dif-
ferent intermolecular-contact regions. The molecules
are packed so that two types of channels (large and
small) with diameters of about 43.3 and 90.0 Å, respec-
tively, are formed along the short axis (Fig. 5b). The
amino-acid residues involved in contacts are located in
domains 1, 2, 4, 5, and 6 (Table 3). In this packing, the
R701-containing loop points toward the center of the
large channel and, consequently, is not involved in
intermolecular contacts. The fact that the electron den-
sity for the region containing this residue is well
defined can be attributed to efficient proteinase inhibi-
tion.
Labile metal-binding sites. As was shown earlier,
CP contains not only three mononuclear and one trinu-
clear copper-binding site but also two so-called labile
metal-binding sites in domains 4 and 6 [9–11]. In the
site belonging to domain 4, the residues H602, E597,
D684, and E971 (from domain 6) are coordinated as
ligands to the metal atoms. In the site belonging to





Fig. 3. Position of the residue His980 in the CP structures at






Fig. 4. Crystal packings of CP: (a) trigonal space group, (b) orthorhombic space group.
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(from domain 2) serve as ligands. The labile sites are
located at a distance of around ~9 Å from the mononu-
clear sites of the corresponding domains. According to
the results of the earlier studies, the labile sites are
occupied predominantly by copper. The iron, nickel,
zinc, and calcium contents are lower than 1, 1, 2, and
4%, respectively [17].
In the present study, the CP structure containing no
ions in the labile sites was obtained for the first time.
This is, apparently, associated with the use of EDTA for
the protein isolation. This allowed us to reveal the con-
formational changes attendant upon ion binding in
these sites.
In the CP structure with the unoccupied labile sites,
the residues D684 (domain 4) and D1025 (domain 6)
point outward, to the intermolecular-contact region,
due to which the labile sites are accessible. According
to the anomalous scattering data, the isolation of CP in
the presence of a nickel salt led to the binding of Ni2+ in
both labile sites (Fig. 6). The binding of the metal ions
is accompanied by the twist of the carboxyl groups of
D684 and D1025 (Fig. 7). The analysis of the anoma-
lous difference electron density maps revealed two
strong peaks with a height of 10σ. A comparison of the
temperature factors shows that the site in domain 6 is
completely occupied by nickel, whereas the occupancy
of the site in domain 4 is 50%. In the structure of CP
solved at 3.1 Å resolution [10], the labile sites are occu-
pied by Cu2+ ions in a similar manner. In the structure
solved at 2.8 Å resolution [11], only the labile site in
domain 6 is half-occupied by copper, whereas the site
in domain 4 is unoccupied. Conceivably, the copper
ions were lost in the course of purification. Therefore,
the copper ions in the labile sites are easily released
and/or are replaced by other ions. Interestingly, the site
in domain 4 is always less occupied than the site in
domain 6, which may be indicative of the different
functions of these sites.
Earlier investigations of the binding of various ions
(Cu2+, Co2+, Fe2+, and Fe3+) in the labile sites [9]
showed that the Cu2+ ions located in the labile sites of
domains 4 and 6 are replaced by Co2+ ions. Copper ions
in the labile sites can also be replaced by Fe2+ ions, but
the latter migrate to putative binding sites (postulated
by Lindley et al. [9]) after oxidation to Fe3+. The Fe3+
ion replaces Cu2+ only in the labile site of domain 6 and
also moves to the putative site.
Nickel is bound in the labile sites analogously to
copper and cobalt ions. Since the concentration of
nickel in blood plasma is normally very low compared
to other microelements, the role of the labile sites of CP
in the exchange of this metal is normally unlikely to be
essential. However, the activity of CP decreases upon











Fig. 5. Intermolecular contact involving R701 in the trigo-
nal crystal structure.
Fig. 6. Peaks in the anomalous difference electron density map in the Ni2+-binding sites.
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Chronic intoxication of rats with nickel causes a com-
pensatory increase in the CP content [34]. It is conceiv-
able that CP is involved in the multicomponent bio-
chemical system of detoxication by binding heavy met-
als in the labile sites.
Another hypothesis about the role of the labile sites
can be made on the basis of studies of the enzymatic
properties of CP. In a study on the site-directed
mutagenesis of the amino-acid residues that form the
labile sites, the substitutions in both domains
(E597A/H602A and E935A/H940A) were shown to
cause a decrease in ferroxidase activity of CP [35]. Sub-
stitutions in domain 6 have no effect on oxidation of the
synthetic diamine Ó-dianisidine. However, the substitu-
tion E971A in the labile site of domain 4 led to an
increase in diamine oxidase activity. In our experi-
ments, no substantial differences were found in oxida-
tion of Ó-dianisidine catalyzed by CP containing or
lacking Ni2+ ions. In CP, the binding site of biogenic
amines (adrenaline, noradrenaline, serotonin, and dihy-
droxyphenylalanine) is located in domain 6 in the
vicinity of the labile metal-binding site (E935, H940,
D1025, and E272) and the mononuclear copper-bind-
ing site. The binding site of synthetic aromatic
diamines is located in domain 4, also in the vicinity of
the labile metal-binding site (E597, H602, D684, and
E971) and the corresponding mononuclear site [10].
Hence it can be suggested, with a degree of certainty,
that the electron transfer from the substrate to the cop-
per ions in the catalytic site of CP rather than the bind-
ing of metal ions in the labile sites plays a decisive role
in oxidation of Ó-dianisidine.
In addition to CP, a labile copper-binding site was








Fig. 7. Conformational changes observed upon metal binding in the labile sites of CP: (a) in domain 6; (b) in domain 4; CP-Ca2+
and CP-ë‡2+ + Ni2+ are light gray and dark gray, respectively.
Table 3.  Intermolecular contacts in CP (Å)
Trigonal sp. gr. Orthorhombic sp. gr.
molecule A molecule B distance molecule A molecule B distance
Lys 557 NZ Tyr 716 OH 3.04 Arg 774 NH2 Gln 985 OE1 2.50
Asn 697 ND2 Ser 771 OG 2.72 Thr 772 CG2 Glu 145 OE2 3.10
Arg 701 NH2 Pro 829 O 3.05 Thr 583 OG1 PHE 414 N 2.94
Arg 701 NH2 Glu 834 OE1 2.98 Arg 579 NH2 Thr 493 OG1 2.84
Arg 701 NE Glu 834 OE2 3.15 Met 580 O Lys 449 NZ 4.02
Glu 712 OE1 Asp 554 N 2.83 Arg 579 NH1 Pro 492 O 2.81
Lys 802 NZ Asp 556 OD1 2.55 Ser 222 O Asp 15 OD2 2.84
His 922 ND1 Ser 341 OG 3.55 Thr 219 O Tyr 220 OH 3.13
Thr 837 N Cys 699 O 3.16 Glu 223 OE1 Arg 46 NH2 3.23
Arg 125 NH1 Asp 122 OD1 2.83 Glu 223 OE2 His 20 N 2.49
Arg 125 NH2 Asp 122 OD2 2.85
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of 7.5 Å from the mononuclear site [36]. In spite of the
fact that the labile binding site of CueO is not suitable
for binding of Fe2+ ions, this oxidase exhibits weak fer-
roxidase activity in vitro. Like amino-acid substitutions
in CP [35], amino-acid substitutions in the labile site of
CueO lead to a decrease in oxidase activity of this
enzyme [36]. On the contrary, copper ions in the unal-
tered labile sites cause an increase in oxidase activity of
CueO [36]. The presence of iron ions leads to an
increase in oxidase activity of CP [37]. Since these sites
in each oxidase are suitable for labile binding of partic-
ular ions, the latter are conceivably involved in more
efficient electron transfer to the type-I copper ion
located in the catalytic sites of both CP and CueO.
Apparently, the labile sites of CP are multifunctional.
On the one hand, these sites can bind metal ions poten-
tially toxic to organisms; on the other hand, they can
facilitate electron transfer from iron ions in the ferroxi-
dase reaction and can be involved in electron transfer
from other substrates of CP. This is additional evidence
that CP is a multifunctional protein playing a role in
various processes proceeding in organisms.
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